NCT07368842Recruiting
Scalp Hair Metabolomics in Severe Obesity
Scalp Hair Metabolomics as a Novel Biomarker of Poor Metabolic Health in Individuals With Severe Obesity
Source: ClinicalTrials.gov · Last updated 13 Feb 2026
Brief summary (registry, in English)
The purpose of this research study is to investigate how body weight and weight-loss surgery affect the natural chemicals found in scalp hair over time. We will also find out how common and severe hair thinning/hair loss and muscle loss are in the first 6 months after bariatric surgery.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 20 Jan 2026
- Start date
- 7 Feb 2026
- Primary completion date
- Feb 2028
- Lead sponsor
- Singapore General Hospital
- Diseases
- Obesity
- NCT number
- NCT07368842
What you commit to
- Study type: Observational
- Planned participants: 60
- From 7 Feb 2026 to the primary completion date, Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any history of autoimmune or scarring alopecia (eg. alopecia areata, discoid lupus, lichen planopilaris)
Other
- Pregnancy
- Any factors likely to limit adherence to study protocol
Who the study is looking for
- All subjects:
- Age 21-70 years
- Ability to provide informed consent
- Healthy weight controls:
- BMI of 18.5-24.9 kg/m2
- No chronic disease
- No long-term medications
- Severe obesity:
- BMI of \> 32.5 kg/m2
- Scheduled to undergo bariatric surgery
Age in the registry: 21 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Singapore General Hospital Coordinator of this site? Confirm its status | Singapore | Singapore | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.